D A Engel

Author PubWeight™ 17.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 An adenovirus early region 4 gene product is required for induction of the infection-specific form of cellular E2F activity. Genes Dev 1989 1.82
2 Transcriptional repression of the c-fos gene by YY1 is mediated by a direct interaction with ATF/CREB. J Virol 1995 1.73
3 Human SWI-SNF component BRG1 represses transcription of the c-fos gene. Mol Cell Biol 1999 1.68
4 Interferons as gene activators. Cloning of the 5' terminus and the control segment of an interferon activated gene. J Biol Chem 1986 1.53
5 Induction of transcription factor AP-1 by adenovirus E1A protein and cAMP. Genes Dev 1989 1.42
6 Interferons as gene activators. Indications for repeated gene duplication during the evolution of a cluster of interferon-activatable genes on murine chromosome 1. J Biol Chem 1989 1.28
7 Interferon action: transcriptional control of a gene specifying a 56,000-Da protein in Ehrlich ascites tumor cells. Virology 1985 1.08
8 Induction of AP-1 DNA-binding activity and c-fos mRNA by the adenovirus 243R E1A protein and cyclic AMP requires domains necessary for transformation. J Virol 1992 1.00
9 Interferons as gene activators. Characteristics of an interferon-activatable enhancer. J Biol Chem 1987 0.97
10 Tip60 degradation by adenovirus relieves transcriptional repression of viral transcriptional activator EIA. Oncogene 2012 0.96
11 Adenovirus E1A specifically blocks SWI/SNF-dependent transcriptional activation. Mol Cell Biol 1996 0.96
12 Identification of a novel E1A response element in the mouse c-fos promoter. J Virol 1995 0.92
13 Adenovirus E1A243 disrupts the ATF/CREB-YY1 complex at the mouse c-fos promoter. J Virol 1995 0.87
14 Cyclic AMP signaling is required for function of the N-terminal and CR1 domains of adenovirus E1A in Saccharomyces cerevisiae. Oncogene 1995 0.81
15 Acetylation and phosphorylation of choline following high or low affinity uptake by rat cortical synaptosomes. Neurochem Res 1982 0.76
16 Recent developments in health insurance and life insurance case law. Tort Insur Law J 1998 0.75